MS Speaks

Multiple Sclerosis => TREATMENTS => BRIUMVI (ublituximab) => Topic started by: agate on May 05, 2026, 09:00:17 pm

Title: (AAN abst.) Safety and tolerability of a modified ublituximab dosing regimen: ENHANCE study updates
Post by: agate on May 05, 2026, 09:00:17 pm

Presented at the recent (April) annual AAN conference--"Safety and tolerability of a modified ublituximab dosing regimen:  Updates from the ENHANCE study":


https://index.mirasmart.com/AAN2026/PDFfiles/AAN2026-003298.html